RBD-7022 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Hyperlipidemia.

KI-3106 is under clinical development by Kuhnil Pharmaceutical and currently in Phase I for Hyperlipidemia. According to GlobalData, Phase I drugs for Hyperlipidemia have a 72% phase transition ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

People who are monitoring their heart health should avoid certain kinds of food. These foods, some of which may be surprising ...

Low-density lipoprotein cholesterol (LDLC), also known as ‘bad cholesterol,’ contributes to plaque buildup in the arteries and causes damage, making it a ‘silent killer’ ...

For weight loss drugs like Ozempic and Wegovy, 2024 was a big year. More patients are relying on them to manage their weight, treat diabetes, or prevent heart attacks and strokes. And while they are ...

Coss Marte opened the first adult-use cannabis dispensary on Manhattan's Lower East Side — the same neighborhood where he ...

If you have a heart condition and are planning to travel soon preparation is essential Evaluate your risks pack necessary ...

Doctors used to recommend no more than 300 mg of dietary cholesterol per day, but new guidelines recommend limiting saturated ...